In summary, pathway enrichment analyses revealed a tight association of ERFE overexpression with GPCR-activated pathways, activated PI3K-AKT signaling pathway, as well as changes in TME, including ECM remodeling, inflammation, and immune cell recruitment, the processes that are crucially involved in the progression of multiple cancers. The gene discussed is ERFE; the disease is cancer.